Enlivex ENLV
NASDAQ ENLV
$1.47 -0.03 (-2.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enlivex (ENLV) Change in Acquisitions & Divestments (2014 - 2025)

Enlivex (ENLV) posted quarterly Change in Acquisitions & Divestments of $10.9 million for Q4 2025, up 156.4% year-over-year from $4.2 million in Q4 2024, and up 9.93% quarter-over-quarter from $9.9 million in Q3 2025.

Enlivex (ENLV) Change in Acquisitions & Divestments (2014 - 2025) Analysis & Trends

Enlivex's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $10.9 million for Q4 2025.

  • In Q4 2025, Change in Acquisitions & Divestments rose 156.4% year-over-year to $10.9 million; the TTM figure through Dec 2025 stood at $41.4 million (up 5.42% YoY), while the FY2025 annual figure was $41.4 million, up 5.42% from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 stood at $10.9 million, up from $9.9 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $62.5 million in Q1 2022, with the low at -$52.5 million in Q3 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $9.9 million (2025), against an average of $10.1 million.
  • The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments sank 620.13% in 2022, then jumped 11745.1% in 2024.
  • Enlivex's Change in Acquisitions & Divestments stood at $17.9 million in 2021, then soared by 192.95% to $52.5 million in 2022, then slumped by 102.72% to -$1.4 million in 2023, then jumped by 397.48% to $4.2 million in 2024, then surged by 156.4% to $10.9 million in 2025.
  • Business Quant data shows ENLV's Change in Acquisitions & Divestments at $10.9 million in Q4 2025, $9.9 million in Q3 2025, and $8.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Enlivex 4.51 Mn -1.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 10.88 Mn
Dec 31, 2025 10.88 Mn
Sep 30, 2025 9.90 Mn
Sep 30, 2025 9.90 Mn
Jun 30, 2025 8.17 Mn
Jun 30, 2025 8.17 Mn
Mar 31, 2025 12.41 Mn
Mar 31, 2025 12.41 Mn
Dec 31, 2024 4.25 Mn
Dec 31, 2024 4.25 Mn
Sep 30, 2024 12.08 Mn
Sep 30, 2024 12.08 Mn
Jun 30, 2024 9.51 Mn
Jun 30, 2024 9.51 Mn
Mar 31, 2024 13.40 Mn
Mar 31, 2024 13.40 Mn
Dec 31, 2023 -1.43 Mn
Dec 31, 2023 -1.43 Mn
Sep 30, 2023 102,000.00
Sep 30, 2023 102,000.00